<img alt="" height="1" width="1" />Piper Jaffray Overweight On Salix Pharmaceuticals, Has $58 Target (SLXP)Benzinga... the pharmaceutical company reported much better than expected earnings yesterday after the bell on sales of Xiafan, its irritable bowel syndrome drug. ...<nobr></nobr> |